Increased Cerebral Blood Flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles

Autor: Peter C.T. Hawkins, Pierluigi Selvaggi, Juergen Dukart, Steven Williams, Mitul A. Mehta, Ottavia Dipasquale, Fabio Sambataro, Alessandro Bertolino, Federico Turkheimer, Mattia Veronese, Gaia Rizzo, Fernando Zelaya, Giulio Pergola
Rok vydání: 2018
Předmět:
Fluorine Radioisotopes
medicine.medical_treatment
Hemodynamics
DR
0302 clinical medicine
Antipsychotics
ASL
CBF
D
2
R
DRD2
mRNA expression
PET
D2R
0303 health sciences
education.field_of_study
Cross-Over Studies
05 social sciences
Brain
Human brain
Risperidone
Healthy Volunteers
Dopamine D2 Receptor Antagonists
medicine.anatomical_structure
Neurology
Cerebral blood flow
Fallypride
Olanzapine
Cerebrovascular Circulation
Benzamides
Antipsychotic Agents
Adult
medicine.medical_specialty
Cognitive Neuroscience
Population
050105 experimental psychology
03 medical and health sciences
Double-Blind Method
Dopamine receptor D2
Internal medicine
medicine
Humans
0501 psychology and cognitive sciences
RNA
Messenger

education
Antipsychotic
030304 developmental biology
Receptors
Dopamine D2

business.industry
Binding potential
Endocrinology
Positron-Emission Tomography
Haloperidol
Spin Labels
business
030217 neurology & neurosurgery
Zdroj: Selvaggi, P, Hawkins, P C T, Dipasquale, O, Rizzo, G, Bertolino, A, Dukart, J, Sambataro, F, Pergola, G, Williams, S C R, Turkheimer, F, Zelaya, F, Veronese, M & Mehta, M A 2019, ' Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles ', NeuroImage, vol. 188, no. 0, pp. 774-784 . https://doi.org/10.1016/j.neuroimage.2018.12.028
DOI: 10.1101/336933
Popis: As a result of neuro-vascular coupling, the functional effects of antipsychotics in human brain have been investigated in both healthy and clinical populations using haemodynamic markers such as regional Cerebral Blood Flow (rCBF). However, the relationship between observed haemodynamic effects and the pharmacological action of these drugs has not been fully established. Here, we analysed MRI-based rCBF data from a placebo-controlled study in healthy volunteers, who received a single dose of three different D2 receptor antagonists and tested the association of the main effects of the drugs on rCBF against normative population maps of D2R protein density and gene-expression data. In particular, we correlated CBF changes after antipsychotic administration with non-displaceable binding potential (BPND) template maps of the high affinity D2-antagonist Positron Emission Tomography (PET) ligand [18F]Fallypride and brain post-mortem microarray mRNA expression data for the DRD2 gene. For all antipsychotics, rCBF changes were directly proportional to brain D2R densities and DRD2 mRNA expression measures, although PET BPND spatial profiles explained more variance as compared with mRNA profiles (PET R2 range= 0.20-0.60, mRNA PET R2 range 0.04-0.20, pairwise-comparisons all p2R profiles varied between the different antipsychotics tested, possibly reflecting differential affinities. Overall, these results indicate that the functional effects of antipsychotics as measured with rCBF are tightly correlated with the distribution of their target receptors in striatal and extra-striatal regions. Our results further demonstrate the link between neurotransmitter targets and haemodynamic changes reinforcing rCBF as a robust in-vivo marker of drug effects. This work is important in bridging the gap between pharmacokinetic and pharmacodynamics of novel and existing compounds.
Databáze: OpenAIRE